Chemotherapy added to tamoxifen can improve outcomes for postmenopausal breast cancer patients, according to a landmark study by the Southwest Oncology Group. But a related study finds that a multigene test on tumors can identify a subset of patients who may not benefit from that chemotherapy.
Launched with federal stimulus funds, new CANCERGEN center’s vision is to make Southwest Oncology Group a national leader in cancer comparative effectiveness research.
Five talented researchers who are early in their career will attend a three-day Southwest Oncology Group workshop for intensive training in how to design and conduct cancer clinical trials.
The Cookeville Times of Tennessee recognized the Cookeville Regional Cancer Center for its recent affiliation with SWOG through the University of Tennessee Health Care System.
Chemotherapy added to tamoxifen can improve outcomes for postmenopausal breast cancer patients, according to a landmark study by the Southwest Oncology Group. But a related study finds that a multigene test on tumors can identify a subset of patients who may not benefit from that chemotherapy.
